Tibbs Isaiah Becomes Beneficial Owner of 8.67% of CERO Therapeutics Holdings, Inc.

Tibbs Isaiah has acquired beneficial ownership of 1,830,007 shares of CERO Therapeutics Holdings, Inc. common stock, representing 8.67% of the outstanding shares. This filing, a Schedule 13G, indicates that the securities were not acquired for the purpose of influencing or changing the control of the issuer. The acquisition date is February 19, 2026, and the filing date is March 12, 2026. Tibbs Isaiah, a U.S. citizen, holds sole voting and dispositive power over these shares. The principal business office of the issuer is located at 201 Haskins Way, Suite 230, South San Francisco, California 94080.